Digipharm

Digipharm

Created using Figma
Created using Figma
Digipharm bypasses infrastructural limitations to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of unprecedented evidence platforms and the ability to reward patients for contributing their data. We aim to utilize innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivize innovation and expedite the transformation to personalized healthcare. Our solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach.
May, 2018
May, 2018
100% completed
Raised funds - no Data
past
Token Details
Accepted Currencies
ETH
Company Details
Registered Country
Switzerland
Additional Details
KYC
Yes
Categories
Health

About Digipharm

Digipharms’ solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach. The inherent flaws of current global healthcare infrastructure result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the patient. In healthcare today, there is a lack of incentive for health systems and providers to focus on mutually beneficial collaboration and the maximisation of patient outcomes.

Digipharm aims to utilise innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalised healthcare.

Activity

Activity:
1 806
VERY HIGH
Posts:
9 841
VERY HIGH
Views:
86 169
VERY HIGH
Activity:
1 806
VERY HIGH
Merit:
1 023
VERY HIGH
Posts:
9 841
VERY HIGH
Views:
86 169
VERY HIGH
Users:
2 685
VERY HIGH
Posts:
213
MEDIUM
Followers:
3 424
MEDIUM
Likes:
3 315
MEDIUM
Rating:
5
VERY HIGH
Followers:
2 559
MEDIUM
Tweets:
342
HIGH
30 Days Growth:
10
Members:
2 303
MEDIUM
30 Days Growth:
18

Digipharm Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Ahmed Abdulla
Founder/CEO
unverified
Girisha Fernando
Co-Founder/COO
unverified
Zach Daniels
CTO
unverified

3 ICO

$13 300 000

Ralf Gerteis
Commercial Strategy
unverified

3 ICO

$5 040 000

Alexander Sverdlov
Cybersecurity Strategy
unverified
Meredith Darden
Digital Marketing Lead
unverified
Alexey Popov
Web Development
unverified
Michael Gubert
UI/UX Design
unverified
Leon Rebolledo
Lead Architect
unverified
Rolf Günter
Legal Counsel
unverified
Bobby Kaura
Business Development
unverified
Mohamed Abdulla
Clinical Transformation
unverified
Hasham Al-Meshhedani
Patient Engagement
unverified
Ali Al-Sudani
Clinical Pharmacist
unverified
Rami Radwan
Clinical Relations
unverified
Peter Sandbach
Communications Director
unverified
Debra De Silva-Sun
HEOR & Pricing Analyst
unverified
Marko Granic
Graphic Designer
unverified
Claudio Staub
Co-Head Startup Communications Farner Consulting A...
unverified
Anas Aman
Quality and Testing IBM
unverified
Per-Olof Thuresson
Health Economist Roche
unverified
Fadi Chehadah
Health Economist NICE UK
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

2 ICO

$5 132 635

Sven Möller
ICO Advisor Swisscom Blockchain AG
unverified
Kamal Youssefi
Enterprise Blockchain Advisor Swisscom Blockchain...
unverified
Waldemar Scherer
Life Sciences Blockchain Advisor Swisscom Blockcha...
unverified
Sam Mantle
Health & Life Sciences Technology Advisor Luxoft
unverified

4 ICO

$8 500 000

Daniel Heller
PR Advisor Partner, Farner Consulting AG
unverified
Lloyd Jefferies
CRM Advisor KPMG
unverified

Digipharm Last News

  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO